United States - English - NLM (National Library of Medicine)

henry schein, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium (mg++) level is usually below the lower limit of normal (1.5 to 2.5 meq/liter) and the serum calcium (ca++) level is normal (4.3 to 5.3 meq/liter) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection, usp is also indicated for the prevention and control of seizures (convulsions) in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block and myocardial damage.

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.2 meq/l) or elevated. in total parental nutrition (tpn), magnesium sulfate may be added to the nutriend admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

United States - English - NLM (National Library of Medicine)

braintree laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - suflave is indicated for the cleansing of the colon as a preparation for colonoscopy in adults. suflave is contraindicated in the following conditions: - gastrointestinal obstruction or ileus [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any ingredient in suflave  [see warnings and precautions ( 5.8)] risk summary there are no available data on the use of suflave during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride (suflave). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other ad

Malta - English - Medicines Authority

fresenius medical care deutschland gmbh d-61346 bad homburg, germany - calcium chloride, dihydrate, glucose, glucose monohydrate, magnesium, magnesium chloride, hexahydrate - solution for haemofiltration - calcium chloride dihydrate 2.033 g/l chloride 111 mmol/l calcium 10 mmol/l glucose 2.982 mmol/l glucose monohydrate 30 g/l magnesium 82 mmol/l magnesium chloride hexahydrate 22 g/l - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

gambro lundia ab - disodium phosphate, dihydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, potassium chloride - solution for haemodialysis, solution for haemofiltration - disodium phosphate dihydrate 0.187 gram(s)/litre ; magnesium chloride hexahydrate 3.05 gram(s)/litre ; sodium chloride 7.01 gram(s)/litre ; sodium hydrogen carbonate 2.12 gram(s)/litre ; potassium chloride 0.314 gram(s)/litre - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter healthcare limited - calcium chloride; icodextrin; magnesium chloride anhydrous; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride 96 mmol/l; icodextrin 7.5 % (w/v); magnesium chloride anhydrous 40 mmol/l; sodium chloride 1.75 mmol/l; sodium lactate 0.25 mmol/l - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 20 g/l; magnesium chloride hexahydrate 0.068 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 9.29 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 33.3 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 21.12 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.257 g/l; glucose monohydrate 42.5 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.12 g/l - blood substitutes and perfusion solutions